![]() | ![]() |
Formats:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright : © 2004 Ransom et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited The Zebrafish moonshine Gene Encodes Transcriptional Intermediary Factor 1γ, an Essential Regulator of Hematopoiesis 1Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America 2Division of Hematology/Oncology, Children's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America 3Department of Molecular, Cell and Developmental Biology, University of California, Los Angeles, California, United States of America 4Department of Pediatrics and Center for Human Genetics and Molecular Pediatric Disease, University of Rochester Medical Center, Rochester, New York, United States of America Corresponding author.David G Ransom: zon/at/enders.tch.harvard.edu Received January 20, 2004; Accepted May 26, 2004. See "A Red-Blooded Transcription Factor" , e282. This article has been cited by other articles in PMC.Abstract Hematopoiesis is precisely orchestrated by lineage-specific DNA-binding proteins that regulate transcription in concert with coactivators and corepressors. Mutations in the zebrafish moonshine (mon) gene specifically disrupt both embryonic and adult hematopoiesis, resulting in severe red blood cell aplasia. We report that mon encodes the zebrafish ortholog of mammalian transcriptional intermediary factor 1γ (TIF1γ) (or TRIM33), a member of the TIF1 family of coactivators and corepressors. During development, hematopoietic progenitor cells in mon mutants fail to express normal levels of hematopoietic transcription factors, including gata1, and undergo apoptosis. Three different mon mutant alleles each encode premature stop codons, and enforced expression of wild-type tif1γ mRNA rescues embryonic hematopoiesis in homozygous mon mutants. Surprisingly, a high level of zygotic tif1γ mRNA expression delineates ventral mesoderm during hematopoietic stem cell and progenitor formation prior to gata1 expression. Transplantation studies reveal that tif1γ functions in a cell-autonomous manner during the differentiation of erythroid precursors. Studies in murine erythroid cell lines demonstrate that Tif1γ protein is localized within novel nuclear foci, and expression decreases during erythroid cell maturation. Our results establish a major role for this transcriptional intermediary factor in the differentiation of hematopoietic cells in vertebrates. Introduction Hematopoiesis involves the coordinated processes of cell proliferation and differentiation of a relatively small number of progenitor cells into billions of circulating red and white blood cells (Thisse and Zon 2002). Hematopoiesis in vertebrates, from zebrafish to humans, is an evolutionarily conserved program that produces two waves of stem or progenitor cells that differ both in their embryonic origins and in the lineages of differentiated blood cells produced (Palis and Yoder 2001; Orkin and Zon 2002; Galloway and Zon 2003). The first, or primitive, wave of hematopoiesis originates from ventral mesoderm and gives rise to progenitor cells that differentiate in embryonic blood islands. The primitive wave of hematopoiesis produces a burst of embryonic erythrocytes and macrophages. The second, or definitive, wave of hematopoiesis arises from self-renewing stem cells that develop primarily in the intraembryonic aorta–gonad–mesonephros region. These definitive hematopoietic stem cells seed the later developing marrow spaces, to produce all lineages of adult blood cells, including definitive erythrocytes, myeloid cells, and lymphocytes. We have undertaken a genetic approach to characterize genes that control hematopoiesis using the zebrafish as a model system (Thisse and Zon 2002). As part of a large-scale forward genetic screen, we previously identified bloodless zebrafish mutants that failed to express the erythroid transcription factor gata1 normally in embryonic hematopoietic precursors (Ransom et al. 1996). We named one of these zebrafish genes moonshine (mon), and another group named a noncomplementing allele vampire (Weinstein et al. 1996). Here, we have determined that mutations in the mon gene cause a disruption in both primitive embryonic and definitive adult hematopoiesis, resulting in a severe loss of erythroid cells. Erythroid progenitor cells in mon mutants are initially present, but fail to express normal levels of hematopoietic transcription factors and undergo apoptosis. Positional cloning identifies the mon gene as the zebrafish ortholog of mammalian transcriptional intermediary factor 1γ (TIF1γ), a member of the TIF1 family of transcriptional coactivators and corepressors (Le Douarin et al. 1995; Friedman et al. 1996; Kim et al. 1996; Venturini et al. 1999; Peng et al. 2002). The three members of the vertebrate TIF1 family (α, β, and γ) are large nuclear proteins that each contain an N-terminal RBCC or TRIM domain (Reymond et al. 2001) composed of a RING finger, two B-boxes, and a coiled-coil domain. TIF1 family members also contain a C-terminal plant homeodomain finger and bromodomain that are characteristic of chromatin remodeling factors. TIF1α has been shown to associate with a variety of ligand-bound nuclear hormone receptors (Le Douarin et al. 1995) and function as a coactivator for retinoic acid receptors (Zhong et al.1999). TIF1β has been shown to act as a corepressor for the large family of Krüppel-associated box (KRAB) domain zinc-finger transcription factors (Friedman et al. 1996; Abrink et al. 2001). In contrast, TIF1γ does not associate directly with either nuclear receptors or KRAB domains that bind to the other TIF1 family members (Venturini et al. 1999; Abrink et al. 2001). Biochemical studies also demonstrate that TIF1γ forms both homo-oligomers and hetero-oligomers with TIF1α but not with TIF1β (Peng et al. 2002). The murine Tif1α and Tif1γ genes have not yet been subjected to gene targeting experiments, whereas analysis of mouse mutants demonstrates that Tif1β is required for postimplantation embryogenesis and mesoderm induction in particular (Cammas et al. 2000). Taken together, these studies suggest that a major function of TIF1 family members is to link DNA-binding proteins with other coactivators or corepressors during development. Our studies establish that tif1γ functions as an essential regulator of embryonic and adult hematopoiesis in vertebrates. Cell transplantation studies demonstrate that tif1γ acts in a cell-autonomous manner during embryonic hematopoiesis. The tif1γ gene is expressed specifically in ventral mesoderm and hematopoietic progenitors, then downregulated as erythroid maturation occurs. Tif1γ protein localizes to a novel class of nuclear bodies in both primary mouse embryo fibroblasts and erythroleukemia cell lines. Taken together, our studies demonstrate that Tif1γ is required for normal erythroid cell development and survival. Results The Zebrafish mon Gene Is Essential for Both Primitive and Definitive Erythropoiesis In order to determine when the mon gene is required in development, we first examined hematopoietic gene expression and apoptosis in zebrafish homozygous mon mutant embryos. During embryogenesis, homozygous zebrafish mon mutants have no red blood cells (RBCs) visible in circulation (Ransom et al. 1996; Weinstein et al. 1996). The mon mutants initiate expression of gata1 in hematopoietic cells around the five-somite stage, similar to wild-type embryos (data not shown); however, based on TUNEL staining, the differentiating erythroid cells undergo programmed cell death from the 12-somite stage to 22 h postfertilization (hpf) (Figure 1
We next examined definitive hematopoiesis in rare surviving homozygous adult zebrafish mon mutants. Mutations in mon are generally lethal by 10 to 14 d of development (Ransom et al. 1996), although rare mon homozygous mutants (approximately 1 in 500 bloodless embryos) of all tested alleles survive to adulthood. Adult mon mutants show cardiac hypertrophy, presumably due to the severe anemia leading to a high output state (Figure 2
Positional Cloning Identifies mon as the Zebrafish Ortholog of Mammalian TIF1γ We identified the mon gene by positional cloning using a panel of 2,200 diploid mutants collected from Tübingen background (TU)/WIK strain hybrid parents carrying the montg234 allele. The mon mutant gene was positioned on Chromosome 8 between microsatellite markers z987 and z11001 (Figure 3
The mon gene encodes a member of the TIF1 family of transcriptional cofactors (Figure 3 We have identified ethyl-nitrosourea (ENU)-induced point mutations in three alleles of mon (Figure 3 In order to determine whether tif1γ is expressed in hematopoietic mesoderm, we next examined zebrafish embryos by whole-mount in situ hybridization (Figure 4
Given that mammalian TIF1γ has been shown to form hetero-oligomers with Tif1α (Peng et al. 2002), we searched for additional TIF1 family members in zebrafish to compare with tif1γ. Using zebrafish expressed sequence tag (EST) sequences, we designed primers to RT-PCR amplify a TIF1-related cDNA from embryonic 10-hpf and 24-hpf RNA. This cDNA encodes a predicted zebrafish ortholog of human TIF1α based on predicted amino acid sequences (see Figure 3 Forced Expression of tif1γ Rescues Hematopoiesis in mon Mutants To further confirm that a mutation in the zebrafish tif1γ gene is responsible for the mon mutant phenotype we performed embryo rescue experiments (Figure 5
Marrow Transplantation Rescues Erythropoiesis in mon Mutants The high levels of tif1γ expression in erythroid cells suggest that it functions as a cell-autonomous regulator of gene expression in hematopoietic cells. In order to test this hypothesis, we transplanted wild-type adult zebrafish kidney marrow cells carrying a gata1:green fluorescent protein (GFP) transgene into 48-hpf mon mutant embryos (Figure 5
Tif1γ in Punctate Nuclear Foci Is Developmentally Regulated In order to examine the subcellular distribution of Tif1γ protein, we generated an affinity-purified rabbit polyclonal antiserum directed against the C-terminal 15 amino acids conserved in human TIF1γ and mouse Tif1γ. Immunofluorescence of mouse embryo fibroblast nuclei with the anti-Tif1γ antiserum demonstrates that Tif1γ is localized in small nuclear foci (Figure 6
Discussion The zebrafish is an excellent model system to elucidate the molecular machinery controlling gene expression during hematopoiesis (Thisse and Zon 2002; Galloway and Zon 2003). As part of a large-scale forward genetic screen, we originally identified a complementation group of independent mutant alleles in the zebrafish gene that we named moonshine (Ransom et al. 1996). Positional cloning was used to identify the mon gene, establishing a critical role for a transcriptional intermediary factor, Tif1γ, during hematopoietic development. The mon Gene Encodes the Zebrafish Ortholog of Mammalian TIF1γ Our results strongly support the conclusion that we have positionally cloned the zebrafish mon gene correctly, and it is the ortholog of mammalian Tif1γ. Tif1γ is present in the critical genetic interval encompassing a single approximately 50-kb PAC clone defined by linkage analysis (see Figure 3 Mutations in tif1γ Cause Apoptosis of Erythroid Progenitors Our examination of hematopoietic gene expression, apoptosis, and marrow histology in mon mutants demonstrates that early erythroid progenitors are formed in homozygous mutants, but they fail to properly differentiate and instead undergo programmed cell death (see Figure 1 The zygotic phenotypes of mon mutants may not reveal the function of maternally inherited Tif1γ. Maternally expressed zebrafish Tif1γ may play roles in hematopoiesis or other aspects of organogenesis that are not detectable due to the presence of wild-type mRNA in eggs laid by heterozygous mothers. Analysis of the offspring of homozygous mon mutant female zebrafish will aid in defining the function of this maternal mRNA. The present analysis of zygotic mon mutants provides data that are consistent with the conclusion that tif1γ is essential for erythropoiesis but do not rule out essential functions in other hematopoietic lineages. The hematopoietic phenotype of mon mutants resembles the loss of erythroid cells seen in both mouse Gata1 knockout embryos and zebrafish vlad tepes (gata1) mutant embryos (Fujiwara et al. 1996; Lyons et al. 2002). In an effort to determine if there is a genetic relationship between mon and gata1, we tested their ability to rescue erythropoiesis. Both injection of gata1 mRNA into mon homozygous mutant embryos and injection of tif1γ mRNA into gata1 knock-down embryos failed to rescue hematopoiesis (unpublished data). We also tested for a direct interaction between Tif1γ and Gata1 proteins by coimmunoprecipitation and yeast two-hybrid assays and found no association (unpublished data). Although the mutations in each of these genes arrest cells at a similar stage of development, our results suggest that gata1 and tif1γ act independently. This does not rule out the possibility that parallel genetic pathways involving gata1 and tif1γ, operating together, regulate gene transcription within blood cells. The Role of Tif1γ in Primitive and Definitive Erythropoiesis Taken together, our data suggest that tif1γ is required as a permissive cofactor for the erythroid lineage-specific control of hematopoietic gene expression. We reasonably predict that Tif1γ protein functions as a transcriptional intermediary factor in hematopoietic progenitor cells given that both TIF1α (Zhong et al. 1999) and TIF1β (Friedman et al. 1996; Abrink et al. 2001) have been shown to act as intermediary factors that positively or negatively regulate gene transcription. These studies indicate that TIF1α and TIF1β act as scaffolds that link different classes of DNA-binding proteins and chromatin-associated proteins into larger regulatory complexes. Tif1γ is detected within nuclear foci (see Figure 6 Materials and Methods Zebrafish and mouse strains and studies Zebrafish were maintained and staged as described (Westerfield 1998). The alleles montb222b and montg234 were generated in a large-scale screen for ENU-induced mutations (Ransom et al. 1996) on the TU, whereas the monm262 allele was derived on the AB strain and was originally called vampire (Weinstein et al. 1996). Mapping strains were constructed by mating to WIK or SJD polymorphic strains. Linkage analysis was performed on haploid or diploid embryos obtained from TU/SJD or TU/WIK hybrids. In situ hybridization and stainings of embryos were done as described (Thompson et al. 1998; Liao et al. 2002). In situ hybridization of mouse embryos was performed as described (Kingsley et al. 2001). Genomic DNA isolation, genotyping, AFLP analysis, and chromosomal walking were each performed as previously described (Brownlie et al. 1998; Ransom and Zon 1999). A complete list of primers for genetic mapping, RT-PCR, and sequencing of mon are available on request. mRNA expression constructs, morpholinos, and microinjection The full-length mon cDNA was subcloned into EcoRI and XhoI sites in the pCS2+ vector. Synthetic mRNA was transcribed in vitro, and microinjection was performed essentially as described (Liao et al. 2002). Cell transplantation Whole kidney marrow cells were isolated from adult gata1:EGFP transgenic donors, resuspended in 0.9X phosphate-buffered saline + 5% fetal bovine serum, and injected into the sinus venosus of 2-d-old montg234 −/− and control embryos. Between 102 and 103 kidney marrow cells were injected per embryo. Individual transplanted embryos were anesthetized and visualized daily under an inverted fluorescent microscope (DM-IRE2; Leica, Wetzlar, Germany) for GFP+ cells over a span of 12 d. On day 13 posttransplant, all surviving larvae (12/129; 9%) were placed in tanks and monitored for survival. Antibodies, immunostaining, and immunoblots Antisera against the human C-terminal TIF1γ sequence RRKRLKSDERPVHIK was generated in rabbits (Genemed Synthesis, South San Francisco, California, United States) and affinity purified. Mouse embryonic fibroblasts grown on coverslips were immunostained with HP1α (Chemicon, Temecula, California, United States) and Tif1γ antisera simultaneously. In brief, cells were fixed in 4% paraformaldehyde for 5 min, washed with phosphate-buffered saline, and blocked with 5% serum (PBST) for 30 min. After incubation with the primary antibodies (PBST, 60 min) cells were washed three times with PBST and incubated with secondary antibodies (Jackson Laboratory, Bar Harbor, Maine, United States) followed by three washes in PBST. Cells were embedded with Vectashield/DAPI and analyzed using an Axioplan 2 microscope (Zeiss, Jena, Germany). Digital images were processed using the Volocity 1.0 software (Improvision, Lexington, Massachusetts, United States). G1E cell differentiation experiments were performed essentially as described (Weiss et al. 1997). Transplantation of wild-type zebrafish marrow cells carrying a gata1:GFP transgene into 2-d-old embryos reconstitutes erythropoiesis, but not viability, in montg234 homozygous mutants. Movies of live embryos at day 3 posttransplant highlight less than 100 GFP+ RBCs in circulation. Transplanted cells were observed to proliferate, resulting in thousands of donor-derived erythrocytes 7 d later. Movies present GFP-fluorescent images of live zebrafish larvae. Video S1: Untransplanted Control montg234 Homozygous Mutants Had No Fluorescent Cells in Circulation at 3 Days of Development (13.7 MB MOV). Click here for additional data file.(13M, mov) Video S2: One Day after Transplantation, Less Than 100 GFP+ Erythrocytes Were Visible in the Circulation of Three montg234 Homozygous Mutants (11.3 MB MOV). Click here for additional data file.(11M, mov) Video S3: Untransplanted Control montg234 Homozygous Mutants Had No Fluorescent Cells in Circulation at 9 Days of Development (7.9 MB MOV). Click here for additional data file.(7.6M, mov) Video S4: Seven Days after Transplantation, Thousands of Donor-Derived Erythrocytes Were Visible in the Circulation of a Representative montg234 Homozygous Mutant (11.2 MB MOV) Click here for additional data file.(11M, mov) Accession Numbers The GenBank (http://www.ncbi.nlm.nih.gov/Genbank) accession numbers for the genes and gene products discussed in this paper are fly bonus (AAF19646), human TIF1α (015164), human TIF1β (Q13263), human TIFγ (Q9UPN9), human TIF1γ (Q9UPN9), mon (AY59853), mouse Tif1α (Q64127), mouse Tif1β (AAH58391), and mouse Tif1γ (NP444400). Acknowledgments We thank A. Davidson, J. Amatruda, and J. Christian for critical review of this manuscript; J. Postlethwait and W. Talbot for helpful discussions and experimental advice; B. Weinstein for the gift of the m262 allele of mon; and D. Giarla for administrative assistance. DGR was funded by the American Cancer Society and an award to Oregon Health and Science University by the Howard Hughes Medical Institute (HHMI) Biomedical Research Support Program for Medical Schools. LIZ and SHO are investigators of the HHMI. This work was supported by grants from the National Institutes of Health. Abbreviations
Footnotes Conflicts of interest. The authors have declared that no conflicts of interest exist. Author contributions. DGR, NB, KN, DT, CB, NST, YZ, JP, SHO, and LIZ conceived and designed the experiments. DGR, NB, KN, DT, CB, NST, NPL, WJS, CAL, CH, BAB, and PDK performed the experiments. DGR, NB, KN, DT, CB, NST, NPL, YZ, JP, SHO, and LIZ analyzed the data. DGR, NB, KN, DT, NST, YZ, BAB, SL, and JP contributed reagents/materials/analysis tools. DGR, NB, KN, DT, and LIZ wrote the paper. Academic Editor: William Talbot, Stanford University ¤Current address: Department of Cell and Developmental Biology, Oregon Health and Science University, Portland, Oregon, United States of America Citation: Ransom DG, Bahary N, Niss K, Traver D, Burns C, et al. (2004) The zebrafish moonshine gene encodes transcriptional intermediary factor 1γ, an essential regulator of hematopoiesis. PLoS Biol 2(8): e237. References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
Science. 2002 Jan 18; 295(5554):457-62.
[Science. 2002]Exp Hematol. 2001 Aug; 29(8):927-36.
[Exp Hematol. 2001]Nat Immunol. 2002 Apr; 3(4):323-8.
[Nat Immunol. 2002]Curr Top Dev Biol. 2003; 53():139-58.
[Curr Top Dev Biol. 2003]Science. 2002 Jan 18; 295(5554):457-62.
[Science. 2002]Development. 1996 Dec; 123():311-9.
[Development. 1996]Development. 1996 Dec; 123():303-9.
[Development. 1996]EMBO J. 1995 May 1; 14(9):2020-33.
[EMBO J. 1995]Genes Dev. 1996 Aug 15; 10(16):2067-78.
[Genes Dev. 1996]Proc Natl Acad Sci U S A. 1996 Dec 24; 93(26):15299-304.
[Proc Natl Acad Sci U S A. 1996]Oncogene. 1999 Feb 4; 18(5):1209-17.
[Oncogene. 1999]J Mol Biol. 2002 Jul 12; 320(3):629-44.
[J Mol Biol. 2002]Development. 1996 Dec; 123():311-9.
[Development. 1996]Development. 1996 Dec; 123():303-9.
[Development. 1996]Development. 1996 Dec; 123():311-9.
[Development. 1996]Blood. 2001 Aug 1; 98(3):643-51.
[Blood. 2001]Nat Genet. 1998 Apr; 18(4):338-43.
[Nat Genet. 1998]Methods Cell Biol. 1999; 60():195-211.
[Methods Cell Biol. 1999]EMBO J. 1995 May 1; 14(9):2020-33.
[EMBO J. 1995]Genes Dev. 1996 Aug 15; 10(16):2067-78.
[Genes Dev. 1996]Oncogene. 1999 Feb 4; 18(5):1209-17.
[Oncogene. 1999]Genome Res. 2000 Sep; 10(9):1351-8.
[Genome Res. 2000]Development. 1997 Jan; 124(2):381-9.
[Development. 1997]Proc Natl Acad Sci U S A. 1995 Nov 7; 92(23):10713-7.
[Proc Natl Acad Sci U S A. 1995]J Mol Biol. 2002 Jul 12; 320(3):629-44.
[J Mol Biol. 2002]Genome Res. 2000 Sep; 10(9):1351-8.
[Genome Res. 2000]EMBO J. 1995 May 1; 14(9):2020-33.
[EMBO J. 1995]Mech Dev. 1999 Oct; 88(1):111-7.
[Mech Dev. 1999]Development. 1996 Dec; 123():311-9.
[Development. 1996]Development. 1997 Oct; 124(20):4105-11.
[Development. 1997]Nat Immunol. 2003 Dec; 4(12):1238-46.
[Nat Immunol. 2003]J Biol Chem. 2002 Dec 27; 277(52):50318-25.
[J Biol Chem. 2002]J Cell Sci. 2002 Sep 1; 115(Pt 17):3439-48.
[J Cell Sci. 2002]Mol Cell Biol. 1997 Mar; 17(3):1642-51.
[Mol Cell Biol. 1997]Science. 2002 Jan 18; 295(5554):457-62.
[Science. 2002]Curr Top Dev Biol. 2003; 53():139-58.
[Curr Top Dev Biol. 2003]Development. 1996 Dec; 123():311-9.
[Development. 1996]EMBO J. 1995 May 1; 14(9):2020-33.
[EMBO J. 1995]Mech Dev. 1999 Oct; 88(1):111-7.
[Mech Dev. 1999]Genome Biol. 2003; 4(10):231.
[Genome Biol. 2003]Proc Natl Acad Sci U S A. 1996 Oct 29; 93(22):12355-8.
[Proc Natl Acad Sci U S A. 1996]Proc Natl Acad Sci U S A. 2002 Apr 16; 99(8):5454-9.
[Proc Natl Acad Sci U S A. 2002]Proc Natl Acad Sci U S A. 1996 Oct 29; 93(22):12355-8.
[Proc Natl Acad Sci U S A. 1996]Proc Natl Acad Sci U S A. 2002 Apr 16; 99(8):5454-9.
[Proc Natl Acad Sci U S A. 2002]Nat Genet. 1999 Nov; 23(3):287-95.
[Nat Genet. 1999]Genes Dev. 1996 Aug 15; 10(16):2067-78.
[Genes Dev. 1996]Proc Natl Acad Sci U S A. 2001 Feb 13; 98(4):1422-6.
[Proc Natl Acad Sci U S A. 2001]Mol Cell. 2002 Oct; 10(4):843-55.
[Mol Cell. 2002]Development. 1996 Dec; 123():311-9.
[Development. 1996]Development. 1996 Dec; 123():303-9.
[Development. 1996]Dev Biol. 1998 May 15; 197(2):248-69.
[Dev Biol. 1998]Development. 2002 Feb; 129(3):649-59.
[Development. 2002]Dev Growth Differ. 2001 Apr; 43(2):133-43.
[Dev Growth Differ. 2001]Development. 2002 Feb; 129(3):649-59.
[Development. 2002]Mol Cell Biol. 1997 Mar; 17(3):1642-51.
[Mol Cell Biol. 1997]